Why the PolyNovo (ASX:PNV) share price is sinking 10% lower today

The PolyNovo Ltd (ASX:PNV) share price is sinking lower on Tuesday after the release of a trading update…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The PolyNovo Ltd (ASX: PNV) share price is on the move on Tuesday following the release of a trading update.

In morning trade the medical device company's shares are down a disappointing 10% to $3.04.

What did PolyNovo announce?

PolyNovo's update revealed that the company delivered a 31% increase in sales over the prior corresponding period for the first half of FY 2021.

This was driven largely by a 75% increase in sales during the first quarter, which was offset slightly by slower than expected sales in October and November.

Pleasingly, this softness appears to have ended, with the company's December sales growing strongly and coming in ahead of expectations in the US, New Zealand, and Taiwan markets.

In respect to the key US market, PolyNovo's sales grew 41% during the first half. It is aiming to build on this in the second half with the help of recent appointments.

During the half, PolyNovo hired 12 experienced and dedicated Territory Managers and one sales director in the country. It also notes that it received more requests for proposal (RFP) in the last three months than in the previous nine months, signed two GPOs, and a number of large strategic hospitals.

Management commentary.

PolyNovo's Chairman, David Williams, revealed that COVID-19 had impacted its performance during the first half.

He said: "While we have experienced a few bumps from COVID-19, we have built a significant base of new customers which holds us in a strong position. We will continue to expand our customer base which will enhance our success as the pandemic eases."

The company's Managing Director, Paul Brennan, acknowledges that the near term will be volatile, but remains very positive on the long term.

He commented: "In the short-term forecasting sales will be challenging particularly in the US, however the medium-term outlook is strong, and we continue to see surgeons using and referring NovoSorb BTM to their peers. Once hospitals have more capacity, we will see US and UK sales accelerate just as we have seen in New Zealand and Australia. New geographies offer good opportunities for NovoSorb BTM."

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Alkane, Myer, Premier Investments, and St Barbara shares are sinking today

These shares are having a poor start to the week. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Bank Shares

Why is the Westpac share price being hit so hard today?

The bank is currently the worst-performing member of the big four.

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Appen, Brainchip, GQG, and Star shares are tumbling today

These shares are having a poor finish to the week. But why?

Read more »

Share Fallers

Why AVITA Medical, Lovisa, Star, and Westgold shares are sinking today

These shares are falling more than most on Thursday. But why? Let's find out.

Read more »

A man wearing 70s clothing and a big gold chain around his neck looks a little bit unsure.
Gold

Guess which ASX 200 gold stock just crashed 10%

The ASX 200 gold stock is under heavy selling pressure on Thursday. But why?

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why AVITA Medical, Block, Computershare, and GQG Partners shares are falling today

These shares are having a tough time on hump day. What's going on?

Read more »

Share Fallers

Why did this ASX All Ords stock just crash 17%?

Why is this stock being sold off? Let's see what investors are not happy about.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Fallers

Why Brainchip, Fortescue, Mesoblast, and St George Mining shares are falling

These shares are having a tough time on Tuesday. Why are investors selling them?

Read more »